Helius Medical Technologies, Inc.
HSDT
$6.10
-$0.81-11.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -73.05% | 252.50% | |||
| Total Other Revenue | 0.00% | 0.00% | |||
| Total Revenue | -67.76% | 198.04% | |||
| Cost of Revenue | -21.43% | -17.65% | |||
| Gross Profit | -3,500.00% | 98.53% | |||
| SG&A Expenses | 37.47% | -23.58% | |||
| Depreciation & Amortization | -- | -57.14% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 24.58% | -20.92% | |||
| Operating Income | -29.10% | 23.66% | |||
| Income Before Tax | 2.29% | -6.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.29% | -6.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.29% | -6.57% | |||
| EBIT | -29.10% | 23.66% | |||
| EBITDA | -29.34% | 23.66% | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -- | -- | |||
| Average Diluted Shares Outstanding | -- | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||